Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients

• Main Authors: Francesca Barei (Author), Martina Zussino (Author), Simona Tavecchio (Author), Luisa Angileri (Author), Arianna Rizzo (Author), Paolo Calzari (Author), Angelo V. Marzano (Author), Silvia Ferrucci (Author)
• Format: Book
• Published: MDPI AG, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The main objective was to analyze patient-reported outcomes (PRO) trends over a four-year period in severe atopic dermatitis (AD) patients treated with dupilumab. Methods: data from 126 severe patients receiving dupilumab for at least 48 months were collected. The clinical scores assesse...